We are live on
!
Find out more
Allspring Global Investments Portfolio holdings
AUM
$65.2B
1-Year Est. Return
39.42%
This Fund
S&P 500
This Quarter
Est. Return
-13.84%
1 Year Est. Return
+39.42%
3 Year Est. Return
+106.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$59.9B
AUM Growth
-$19.4B
(-24%)
Cap. Flow
-$7.28B
Cap. Flow
% of AUM
-12.16%
Top 10 Holdings %
Top 10 Hldgs %
12.9%
Holding
3,091
New
65
Increased
556
Reduced
1,970
Closed
397
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vulcan Materials
VMC
|
+$229M |
| 2 |
Charles River Laboratories
CRL
|
+$149M |
| 3 |
Rollins
ROL
|
+$57.6M |
| 4 |
Axalta
AXTA
|
+$55.7M |
| 5 |
Wingstop
WING
|
+$54.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$348M |
| 2 |
Amazon
AMZN
|
+$265M |
| 3 |
Apple
AAPL
|
+$245M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$177M |
| 5 |
Meta Platforms (Facebook)
META
|
+$160M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.35% |
| 2 | Industrials | 12.74% |
| 3 | Healthcare | 12.42% |
| 4 | Consumer Discretionary | 11.91% |
| 5 | Financials | 11.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Conduent
CNDT
$252M
| $126K | ﹤0.01% |
29,207
-153,834
| -84% | -$772K |
|
1977
Harmony Biosciences
HRMY
$2.24B
| $126K | ﹤0.01% |
2,603
-9,531
| -79% | -$429K |
|
1978
BioCryst Pharmaceuticals
BCRX
$2.51B
| $125K | ﹤0.01% |
11,822
-118,438
| -91% | -$1.22M |
|
1979
Cullinan Oncology
CGEM
$1.26B
| $125K | ﹤0.01% |
9,760
+168
| +2% | +$1.91K |
|
1980
O-I Glass
OI
$1.05B
| $125K | ﹤0.01% |
8,952
-98,264
| -92% | -$1.41M |
|
1981
TTM Technologies
TTMI
$14.6B
| $125K | ﹤0.01% |
10,046
-76,427
| -88% | -$1.06M |
|
|
ECOM
1982
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $125K | ﹤0.01% |
8,606
-44,713
| -84% | -$639K |
|
|
BBT
1983
Beacon Financial Corp
BBT
$2.71B
| $124K | ﹤0.01% |
5,027
-25,147
| -83% | -$652K |
|
1984
Dycom Industries
DY
$12.3B
| $124K | ﹤0.01% |
1,337
-11,031
| -89% | -$983K |
|
1985
Yelp
YELP
$1.32B
| $124K | ﹤0.01% |
4,496
-34,592
| -88% | -$1.07M |
|
1986
Bloom Energy
BE
$69.6B
| $122K | ﹤0.01% |
7,415
-32,688
| -82% | -$599K |
|
1987
Constellium
CSTM
$3.95B
| $122K | ﹤0.01% |
9,249
-51,933
| -85% | -$830K |
|
1988
Eagle Bancorp
EGBN
$877M
| $122K | ﹤0.01% |
2,580
-12,488
| -83% | -$628K |
|
1989
Entegris
ENTG
$25B
| $122K | ﹤0.01% |
1,332
-13,956
| -91% | -$1.51M |
|
|
TPTX
1990
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $122K | ﹤0.01% |
1,628
-553,344
| -100% | -$24.6M |
|
1991
Americold
COLD
$4.32B
| $121K | ﹤0.01% |
4,058
-27,347
| -87% | -$760K |
|
1992
Nuveen Taxable Municipal Income Fund
NBB
$456M
| $121K | ﹤0.01% |
6,817
| – | – |
|
1993
Clearwater Paper
CLW
$354M
| $120K | ﹤0.01% |
3,591
+2,550
| +245% | +$79.8K |
|
1994
Lands' End
LE
$390M
| $120K | ﹤0.01% |
11,339
-28,552
| -72% | -$375K |
|
1995
Kymera Therapeutics
KYMR
$9.51B
| $119K | ﹤0.01% |
6,062
-15,134
| -71% | -$353K |
|
1996
Ultragenyx Pharmaceutical
RARE
$2.6B
| $119K | ﹤0.01% |
1,998
-435
| -18% | -$26.8K |
|
1997
United Bankshares
UBSI
$6.68B
| $119K | ﹤0.01% |
3,417
-37,166
| -92% | -$1.3M |
|
1998
Zymeworks
ZYME
$1.83B
| $119K | ﹤0.01% |
22,520
+4,226
| +23% | +$25.6K |
|
|
SPWR
1999
DELISTED
SunPower Corporation Common Stock
SPWR
| $119K | ﹤0.01% |
7,541
-31,761
| -81% | -$572K |
|
2000
N-able
NABL
$695M
| $118K | ﹤0.01% |
13,144
-180,542
| -93% | -$1.77M |
|
Similar funds
Allspring Global Investments's Q2 2022 Portfolio in Review
As of Q2 2022, Allspring Global Investments held 3,091 positions worth $59.9B, down 24% from $79.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Allspring Global Investments withdrew a net $7.28B in Q2 2022, closing 397 positions and reducing 1,970 holdings. Its most notable exit was 51job Inc, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 21% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Allspring Global Investments opened a new position in Liberty Media Series C worth $35.1M.
- Allspring Global Investments's largest Q2 2022 buy was Liberty Media Series C: 572,364 shares worth $35.1M.
- Allspring Global Investments added most to Vulcan Materials in Q2 2022, an estimated $229M increase.
- Allspring Global Investments's biggest Q2 2022 reduction was Microsoft, cutting an estimated $348M.
- Allspring Global Investments fully exited 51job Inc in Q2 2022, selling an estimated $122M.
- Allspring Global Investments's ten largest holdings make up 13% of its $59.9B portfolio in Q2 2022.
- Allspring Global Investments opened 65 new positions and closed 397 in Q2 2022.
- Allspring Global Investments's portfolio value fell 24% quarter-over-quarter to $59.9B.
Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.